Home » Authors » Nuala Moran

Articles by Nuala Moran

ReNeuron Shares Drop On Failed Phase II Trials Of Lead Product

Jan. 22, 2003

Cyclacel Starts Phase II Trials Of Small-Molecule CDK Inhibitor

Jan. 22, 2003

Xenova Paying $1M For Rights To Two Addiction Vaccines

Jan. 22, 2003

Procognia Closes $4M Round, Acquires Sense Proteomic Ltd.

Jan. 22, 2003

Cyclacel Starts Phase II Trials Of Small-Molecule CDK Inhibitor

Jan. 22, 2003

ReNeuron Shares Drop On Failed Phase II Trials Of Lead Product

Jan. 22, 2003

Xenova Paying $1M For Rights To Two Addiction Vaccines

Jan. 22, 2003

Biotica Raises $5M For Work Centered Around Polyketides

Jan. 15, 2003

International Researchers Meet To Coordinate Stem Cell Work

Jan. 15, 2003

Senexis Gets Funding To Push Programs In Diseases Of Aging

Jan. 15, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...